KRAS and neoplasm: It has been show that in KRAS-mutant PDAC, spleen tyrosine kinase (Syk) and tripartite motif containing 21 (TRIM21) accelerate tumor progression toward malignancy by regulating the ubiquitination of BCAT2 to maintain the catabolism and mitochondrial respiration of BCAAs90.